Brokers Issue Forecasts for Daré Bioscience, Inc.'s Q3 2023 Earnings (NASDAQ:DARE)

Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – Brookline Capital Management issued their Q3 2023 earnings estimates for Daré Bioscience in a report released on Monday, June 5th. Brookline Capital Management analyst K. Dolliver expects that the biotechnology company will earn ($0.07) per share for the quarter. Brookline Capital Management currently has a “Buy” rating […]

Related Keywords

Lisa Walters Hoffert ,Sabrina Martucci Johnson ,Blackrock Inc ,Vanguard Group Inc ,Renaissance Technologies ,Millennium Management ,Bioscience Inc ,Nasdaq ,Get Rating ,Brookline Capital Management ,Capital Management ,Bioscience Price ,Funds Weigh In On Dar ,State Street Corp ,Street Corp ,Bioscience Daily ,Daré Bioscience ,Nasdaq Dare ,Dare ,Medical ,Earnings Estimates ,